Elecsys HCG STAT 07229569190Recalls & reported problems
Roche Diagnostics GmbH · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04015630940417), received between Nov 7, 2018 and Nov 7, 2018 — classified as 1 malfunction.
The most frequently reported specific device problem is “Low Test Results” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Low Test Results1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 7, 2018Low Test Results; Low Test Results
THE CUSTOMER QUESTIONED RESULTS FOR 1 MALE PATIENT TESTED FOR ELECSYS HCG + B (HCG + B) AND ELECSYS HCG STAT (HCG STAT) ON A COBAS E801 MODULE. BASED ON THE DATA PROVIDED, THE HCG STAT RESULTS ARE A REPORTABLE MALFUNCTION. THE INITIAL HCG STAT RESULT FROM THE E801 MODULE WAS 2.96 MIU/ML. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE WAS SENT TO AN EXTERNAL LABORATORY USING THE SIEMENS METHOD AND THE HCG RESULT WAS 10.7 MIU/ML. THE SAMPLE WAS SUBMITTED FOR INVESTIGATION AND TESTED ON AN E801 MODULE AT THE INVESTIGATION SITE. THE HCG STAT RESULT WAS 2.61 MIU/ML WHICH CORRESPONDED TO THE CUSTOMER'S RESULT. THERE WAS NO ALLEGATION THAT AN ADVERSE EVENT OCCURRED. THE E801 MODULE SERIAL NUMBER USED AT THE CUSTOMER SITE WAS (B)(4). THE E801 MODULE SERIAL NUMBER USED AT THE INVESTIGATION SITE WAS (B)(4). THE HCG STAT REAGENT LOT NUMBER USED AT THE INVESTIGATION SITE WAS 319823 WITH AN EXPIRATION DATE OF 31-JUL-2019. CALIBRATION AND QC AT THE INVESTIGATION WAS ACCEPTABLE. BASED ON THE DATA AVAILABLE, A REAGENT ISSUE WAS NOT IDENTIFIED. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8047287 ↗
Other SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN devices
- IMMULITE® 2000 Systems HCG 10381206Siemens Healthcare Diagnostics Products Ltd · SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN1 recall173 reports
- ARCHITECT 7K78-25Abbott Ireland · SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN176 reports
- ARCHITECT 7K78-30Abbott Ireland · SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN110 reports
- i-STAT 05p58-25Abbott Point Of Care Inc. · System, Test, Human Chorionic Gonadotropin105 reports
- IMMULITE® 2000 Systems HCG 10381194Siemens Healthcare Diagnostics Products Ltd · SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN1 recall16 reports
- Alinity 07P5121Abbott Ireland · SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN1 recall15 reports
- Elecsys HCG+beta 07251025190Roche Diagnostics GmbH · SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN58 reports
- Elecsys HCG Test System 3271749160Roche Diagnostics GmbH · SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN39 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page